Literature DB >> 11603694

Cartilage damage by matrix degradation products: fibronectin fragments.

G A Homandberg1.   

Abstract

Catabolic cytokines play a major role in cartilage degradation not only in rheumatoid arthritis but also in osteoarthritis. Although the major source in rheumatoid arthritis may be mononuclear cells and synovial tissue and the cause of release may be multifactorial, the source of cytokines in osteoarthritis would be mostly from chondrocytes. However, there are few explanations of how upregulation of the cytokines might occur in osteoarthritis. One possibility is that degradation products of the extracellular matrix arising from elevated protease levels, substrate, or both, might regulate cytokine activities. Fragments of the extracellular matrix protein, fibronectin, upregulate cytokine expression and induce the events of suppressed matrix synthesis and upregulation of matrix metalloproteinases, characteristic of osteoarthritis. The catabolic aspects of this system are short term, subsequently serve to enhance anabolic processes above untreated levels, and condition the tissue against additional insult. It will be necessary to determine whether in vivo these degradation products precede cytokine expression and act early and are targets for intervention or instead are a consequence of cytokine damage. Whether they regulate anabolism and catabolism, blocking of their activities may not be ideal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11603694     DOI: 10.1097/00003086-200110001-00010

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis.

Authors:  Magdalena Przybysz; Dorota Maszczak; Krzysztof Borysewicz; Jacek Szechiński; Iwona Katnik-Prastowska
Journal:  Glycoconj J       Date:  2007-07-03       Impact factor: 2.916

Review 2.  ADAMTS proteins in human disorders.

Authors:  Timothy J Mead; Suneel S Apte
Journal:  Matrix Biol       Date:  2018-06-06       Impact factor: 11.583

3.  Terminal monosaccharide screening of synovial immunoglobulins G and A for the early detection of rheumatoid arthritis.

Authors:  Ewa Maria Kratz; Krzysztof Borysewicz; Iwona Katnik-Prastowska
Journal:  Rheumatol Int       Date:  2009-10-09       Impact factor: 2.631

4.  Full-thickness supraspinatus tears are associated with more synovial inflammation and tissue degeneration than partial-thickness tears.

Authors:  Michael K Shindle; Christopher C T Chen; Catherine Robertson; Alexandra E DiTullio; Megan C Paulus; Camille M Clinton; Frank A Cordasco; Scott A Rodeo; Russell F Warren
Journal:  J Shoulder Elbow Surg       Date:  2011-05-25       Impact factor: 3.019

5.  Down-regulation of programmed cell death 5 by insulin-like growth factor 1 in osteoarthritis chondrocytes.

Authors:  Chengqing Yi; Chunhui Ma; Zongping Xie; Guoqiao Zhang; Wangsheng Song; Xiaokai Zhou; Yun Cao
Journal:  Int Orthop       Date:  2013-01-16       Impact factor: 3.075

6.  Expression of MMP-1 in cartilage and synovium of experimentally induced rabbit ACLT traumatic osteoarthritis: immunohistochemical study.

Authors:  Hongbin Wu; Jingyuan Du; Qixin Zheng
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

7.  Developmental mechanisms in articular cartilage degradation in osteoarthritis.

Authors:  Elena V Tchetina
Journal:  Arthritis       Date:  2010-12-29

8.  Alterative effects of an oral alginate extract on experimental rabbit osteoarthritis.

Authors:  Hsien-Tseng Lu; Ming-Shium Hsieh; Chao-Wen Cheng; Li-Fan Yao; Tsuey-Ying Hsu; Jai Lan; Kwang Yoon Kim; Suk Jung Oh; Yung-Hsiang Chang; Chian-Her Lee; Yung-Feng Lin; Chien-Ho Chen
Journal:  J Biomed Sci       Date:  2015-08-04       Impact factor: 8.410

9.  An intron polymorphism of the fibronectin gene is associated with end-stage knee osteoarthritis in a Han Chinese population: two independent case-control studies.

Authors:  Hsin-Yi Yang; Sui-Lung Su; Yi-Jen Peng; Chih-Chien Wang; Herng-Sheng Lee; Donald M Salter; Chian-Her Lee
Journal:  BMC Musculoskelet Disord       Date:  2014-05-23       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.